• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

炎症性主动脉综合征行 Bentall 手术后左主干冠状动脉开口狭窄行西罗莫司洗脱支架植入术。

Sirolimus-eluting stent implantation for ostial stenosis of left main coronary artery after Bentall operation in aortitis syndrome.

机构信息

Department of Cardiology, Kasugai Municipal Hospital, 1-1-1 Takagi-cho, Kasugai, Aichi 486-8510, Japan.

出版信息

J Cardiol. 2010 Jan;55(1):147-50. doi: 10.1016/j.jjcc.2009.04.013. Epub 2009 Jun 3.

DOI:10.1016/j.jjcc.2009.04.013
PMID:20122564
Abstract

We describe a 66-year-old woman with aortitis syndrome, successfully treated with percutaneous coronary intervention using sirolimus-eluting stent (SES) for ostial stenosis of left main coronary artery after Bentall operation. At one-year follow-up, she had no evidence of restenosis and no clinical events. Stent implantation with SES may be useful for ostial left main coronary stenosis after Bentall operation in selected patients with aortitis syndrome.

摘要

我们描述了一位 66 岁的女性患者，患有巨细胞动脉炎综合征，在 Bentall 手术后因左主干开口狭窄行经皮冠状动脉介入治疗（使用西罗莫司洗脱支架）取得成功。在一年的随访中，她没有出现再狭窄的证据，也没有发生任何临床事件。对于巨细胞动脉炎综合征的选择性患者，支架植入术（使用西罗莫司洗脱支架）可能对 Bentall 手术后的左主干开口狭窄有效。

相似文献

1
Sirolimus-eluting stent implantation for ostial stenosis of left main coronary artery after Bentall operation in aortitis syndrome.炎症性主动脉综合征行 Bentall 手术后左主干冠状动脉开口狭窄行西罗莫司洗脱支架植入术。
J Cardiol. 2010 Jan;55(1):147-50. doi: 10.1016/j.jjcc.2009.04.013. Epub 2009 Jun 3.
2
Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions.西罗莫司洗脱支架植入治疗主动脉开口病变后的临床及血管造影结果。
J Am Coll Cardiol. 2004 Sep 1;44(5):967-71. doi: 10.1016/j.jacc.2004.05.058.
3
Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.西罗莫司洗脱支架与紫杉醇洗脱支架治疗无保护左主干冠状动脉疾病患者的长期临床结局：MAIN-COMPARE（无保护左主干冠状动脉狭窄血运重建：经皮冠状动脉腔内血管成形术与外科血运重建比较）注册研究分析
J Am Coll Cardiol. 2009 Aug 25;54(9):853-9. doi: 10.1016/j.jacc.2009.04.071.
4
Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.裸金属支架与西罗莫司或紫杉醇洗脱支架治疗主动脉开口处冠状动脉疾病的比较。
Cardiology. 2008;111(4):270-6. doi: 10.1159/000128602. Epub 2008 May 2.
5
Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.小冠状动脉中雷帕霉素洗脱支架植入术后心脏事件和再狭窄的预测因素。
Catheter Cardiovasc Interv. 2007 May 1;69(6):821-5. doi: 10.1002/ccd.21019.
6
Sirolimus-eluting stent implantation for chronic total occlusion of the left main coronary artery.西罗莫司洗脱支架植入术治疗左主干冠状动脉慢性完全闭塞病变
J Interv Cardiol. 2005 Feb;18(1):65-9; discussion 69. doi: 10.1111/j.1540-8183.2005.04069.x.
7
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.西罗莫司洗脱支架植入术对初发冠状动脉狭窄糖尿病患者的长期临床益处：糖尿病（DIABETES）试验的长期结果
Eur Heart J. 2007 Aug;28(16):1946-52. doi: 10.1093/eurheartj/ehm197. Epub 2007 Jun 11.
8
Successful management of left main coronary artery stenosis with a paclitaxel-eluting stent in Takayasu's arteritis.用紫杉醇洗脱支架成功治疗高安动脉炎患者的左主干冠状动脉狭窄
Int J Cardiol. 2006 Mar 22;108(1):120-3. doi: 10.1016/j.ijcard.2005.02.024.
9
Percutaneous treatment of the left main coronary artery ostial obstruction following aortic valve replacement.主动脉瓣置换术后经皮治疗左冠状动脉主干开口处梗阻
Ital Heart J. 2005 Sep;6(9):775-7.
10
Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT).药物洗脱支架选择对无保护左主干冠状动脉疾病患者长期临床结局的影响：左主干登记处的西罗莫司与紫杉醇药物洗脱支架（SP-DELFT）。
Int J Cardiol. 2009 Sep 11;137(1):16-21. doi: 10.1016/j.ijcard.2008.06.006. Epub 2008 Aug 6.

引用本文的文献

1
Restenosis after excimer laser coronary atherectomy and drug-coated balloon dilation in Takayasu's arteritis: a case report and review of the literature.Takayasu动脉炎患者准分子激光冠状动脉斑块旋切术及药物涂层球囊扩张术后再狭窄：一例报告并文献复习
Thromb J. 2023 Aug 10;21(1):87. doi: 10.1186/s12959-023-00529-9.
2
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.mTOR（雷帕霉素作用靶点）在风湿性疾病中的激活
Nat Rev Rheumatol. 2016 Mar;12(3):169-82. doi: 10.1038/nrrheum.2015.172. Epub 2015 Dec 24.
3
A Retrograde Approach to Coronary Ostial Stenosis after a Bentall Procedure in a Patient with Behçet's Disease.
贝赫切特病患者 Bentall 手术后冠状动脉开口狭窄的逆行入路
Korean Circ J. 2013 Apr;43(4):277-80. doi: 10.4070/kcj.2013.43.4.277. Epub 2013 Apr 30.